SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

Fusion Pharmaceuticals Q1 EPS $(0.42) Up From $(6.01) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.42) per share. This is a 93.01 percent increase over losses of $(6.01) per share from the same period last year.

05/11/2021 07:54
Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.42) per share. This is a 93.01 percent increase over losses of $(6.01) per share from the same period last year.